GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Discussion] non-peptide is doing more work than we give it credit for — 22 comments in the full submission. View in context.
123
c/orforglipron·submitted 1 months ago by u/kavya_radich

[Discussion] non-peptide is doing more work than we give it credit for

Discussionbranch of 9 comments

Week 24 update. 25kg down from the start, reflux basically gone since about week 76. Things that worked: consistency, protein at breakfast, walking more than I want to. Things that did not: everything I bought on the internet to help with reflux. The part that surprised me is how much of this is admin. Ordering,…

Read the full submission and all 22 comments →

This branch

9 comments, started 1 months ago
u/greta_nilsen26 points·1 months ago

Week 45 for me and the honest summary is: 34kg down, reflux manageable, and I have thought about food maybe four times today.

replysharereportpermalink
u/graph_it_gary21 points·1 months ago

Yeah, small molecule changes the whole game.

replysharereportpermalink
u/ines_lindqvist13 points·1 months ago

the fatigue profile is speculative at this stage

replysharereportpermalink
[removed]18 points·1 months ago

[removed by moderator]

replysharereportpermalink
u/lukas_delgado15 points·1 months ago

This is correct. ATTAIN data is phase 18.

replysharereportpermalink
u/throwaway_wl20264 points·1 months ago

This is correct.

Yes, exactly this, and it is the bit that took me 62 weeks to accept.

replysharereportpermalink
u/declared_value_dv16 points·1 months ago

Yeah, small molecule changes the whole game.

replysharereportpermalink
u/search_before_post19 points·1 months ago

Not convinced. The evidence does not support that reading.

replysharereportpermalink
u/yara_boateng5 points·1 months ago

the nausea profile is speculative at this stage

replysharereportpermalink

← back to the whole thread

About c/orforglipron

The small-molecule oral: why a non-peptide agonist escapes the absorption problems of oral semaglutide, what the ATTAIN and ACHIEVE readouts showed, and what a pill with no refrigeration requirement would do to the entire supply conversation this site is built around.

21kmembers
62submissions
Feb 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
More in c/orforglipron
c/orforglipron rules
  1. Small molecule, not a peptide. Purity discussion here is a different problem.
  2. Cite ATTAIN/ACHIEVE arms specifically when quoting numbers.
  3. Availability speculation must be flaired Speculation.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/incretin_ivyu/phase_two_peteu/trialwatch_theo
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →